ARG1 and chronic myelogenous leukemia, BCR-ABL1 positive: Both Arg1 protein and enzyme activity was higher in CML PMNs than Gr-MDSCs, demonstrating, for the first time, a critical role of CML PMNs on the tumor microenvironment with a potential immunosuppressive activity.